Released in late 2020, this research paper, prepared jointly with the Society of Actuaries, examines lapse and mortality experience on term insurance plans once they reach the end of the initial level premium period. Steve Schumacher, FSA, MAAA, one of the paper’s authors, joins us to discuss their findings and the implications for product pricing.
With almost a year’s exposure to the COVID-19 pandemic, the impact of the virus on Canadian insurers is a topic of interest to actuaries. A CIA Research Council initiative to survey Canadian insurance companies and collect COVID-19 data from their individual and group life business has now produced results. Keith Walter, FCIA, Chair of the Research Council, joins us to provide an overview of...
The process for credit provisioning at banks has similarities with the insurance reserving process that will seem familiar to many actuaries. In this episode, we hear from Mike Donovan and Erik von Schilling, FCIA, as they discuss what is changing with credit provisioning under IFRS 9, and how actuarial skills can potentially be useful in this area.
The CIA has released a public statement entitled “Pharmacare: Is There a Pill for That?” outlining the profession’s thoughts on how a nationwide framework to provide prescription drug coverage for Canadians should be structured. In this episode, we hear from Paul Kennedy, FCIA, a member of the task force that authored the statement, as he outlines some of the statement’s key messages.
This is the second of three discussions about how CIA members have contributed to the profession by working outside of Canada. In this episode, we hear from Mike Hafeman, FCIA, who discusses his extensive international experience, which has taken him to 74 countries, and includes work with diverse locations such as Eritrea, Micronesia, and Eswatini.
Canadian Institute of Actuaries
360 Albert Street, Suite 1740
Ottawa, Ontario K1R 7X7
SeeingBeyondRisk@cia-ica.ca